New combo pill for diabetes and high cholesterol
Part of Hormones & metabolism clinical trials.
This trial tests a new combination pill for people with type 2 diabetes and high cholesterol who are already on metformin. It aims to see if the new drug helps control both blood sugar and cholesterol better than current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 80 years old and live in South Korea.
- You have both type 2 diabetes and high cholesterol (dyslipidemia).
- You take at least 1000 mg of metformin daily, either alone or with another diabetes pill.
- Your most recent HbA1c (average blood sugar) is between 7.0% and 10.5%.
- Your fasting blood sugar is 270 mg/dL or lower.
- Your fasting LDL (bad cholesterol) is between 100 and 250 mg/dL, and your triglycerides are 400 mg/dL or lower.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
This trial tests a combination of three diabetes medicines (henagliflozin proline, retagliptin, and metformin) for people newly diagnosed with type 2 diabetes. The goal is to see how well the combination controls blood sugar and to check its safety.
This study tests a new daily pill (QLG1091) against a similar existing pill (Rybelsus) when both are added to your current metformin treatment for type 2 diabetes. The goal is to see if the new pill is as effective and safe for lowering blood sugar.
This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.
This study combines two different diabetes medications (called DWP16001 and DWC202518) to see if starting them together works better than either one alone for lowering blood sugar. It is for adults with type 2 diabetes who need better control and have not yet tried or have only taken one diabetes pill.
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.